Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981 (Paperback, Softcover reprint of the original 1st ed. 1982)
Loot Price: R1,651
Discovery Miles 16 510
|
|
Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981 (Paperback, Softcover reprint of the original 1st ed. 1982)
Series: Developments in Oncology, 10
Expected to ship within 10 - 15 working days
|
Donate to Gift Of The Givers
Total price: R1,671
Discovery Miles: 16 710
|
F. M. MUGGIA When faced with the inadequacies of current cancer
treatment, we prefer to look at what the future may hold. Quite
often, we take for granted the past, preferring research into
totally new areas. However, the persistent development of fertile
soil may yield surprising rewards for those who choose to build on
the knowledge of the past--hence, this symposium on anthracycline
antibiotics. Although the anthracycline antibiotics represent much
of the present and future of cancer treatment, their actual use c
stretches back barely two decades to the pioneering efforts of
Aurelio Di Marco, who characterized the antitumor properties of
daunomycin and adriamycin. * The clinical application of these two
compounds heralded a decade of excitement among oncologists dealing
with pediatric tumors, breast cancer, leukemias, and lymphomas, and
opened new hope for patients afflicted with sar comas and a variety
of other tumors that had been deemed - sistant to chemotherapy.
These successes were tempered with the realization that the
antitumor effect of anthracyclines could be achieved at times only
at the very high price of risking cardiac decompensation and,
almost invariably, with the occurrence of alopecia and other acute
toxicities. This record of past achievements and problems has
slowly given way to a present increasingly illuminated by our
ability to modify the distressing toxicities of these agents.
Detailed clinical studies supplemented by ingenious laboratory
models have gradually elucidated mechanisms and risk factors im
plicated in the cardiomyopathy."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.